fda compounding semaglutide update Hims & Hers stock falls 25% as curtails compounded GLP-1s Trimi GLP-1 Review 2026: What

Enetic drug target validation using Mendelian randomisation

However, they do come with some side effects, which we will discuss in the next section

As far as what the oral GLP-1 means for the future of Lillys injectable Zepbound (tirzepatide), which saw $5 billion in sales last year (PharmaCircle Key Product Sales), the Lilly spokesperson says: Orforglipron and Zepbound have distinct mechanisms, formulations, and route of administration

Ozempic and Saxenda serve similar purposes but may differ in side effects

Traditionally, select GLP-1 medications were covered by Medicare Part D (the programs prescription drug benefit) to help manage type 2 diabetes and cardiovascular disease